Related Experiment Video
Updated: Nov 7, 2025

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Fungaemia due to rare yeasts in paediatric intensive care units: A prospective study
Harsimran Kaur1, Shreya Singh1, Shivaprakash Mandya Rudramurthy1
1Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Background:
Considering the emergence of fungaemia due to rare yeasts at our centre, we performed a systematic epidemiologic study on fungaemia due to rare yeast.
Objectives:
We undertook the present prospective observational study to explore the epidemiological features and clinical characteristics of fungaemia due to rare yeasts in paediatric ICUs at our centre.
Methods:
The successive yeasts isolated from blood at our PICUs during December 2017 through March 2019 were identified by molecular methods. Fungaemia due to yeasts other than C. albicans, C. tropicalis, C. glabrata, C. krusei and C. parapsilosis was categorised as rare yeasts. Antifungal susceptibility testing of the yeast isolates was performed as per clinical and laboratory standards institute (CLSI) guidelines. We also compared different clinical parameters of fungaemia due to common versus rare yeasts, and rare yeasts in neonates versus non-neonates.
Results:
During the study period, 212 yeast isolates were obtained from 159 patients at PICUs of our hospital, and 127 isolates from 98 patients (61.6%) were categorised as rare yeasts. Neonates acquired fungaemia significantly earlier after ICU admission than non-neonates (median:4 vs 6 days; p = .005). Regarding epidemiology study of rare yeast fungaemia, Wickerhamomyces anomalus (43.8%) and Candida utilis (40.8%) were common isolates; surgical intervention and gastrointestinal disease were significantly associated; overall, azole, echinocandin and amphotericin B resistance was at 9.1%, 1.02% and 1.02%, respectively; overall mortality was 65.3%.
Conclusions:
The emergence of rare yeasts especially W. anomalus and C. utilis causing fungaemia in our children demands urgent attention to control the spread.
Insights
Rare yeasts like Wickerhamomyces anomalus and Candida utilis are increasingly causing fungaemia in children. This study highlights their epidemiology and resistance patterns, demanding urgent control measures.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Epidemiology
Background:
- Fungaemia due to rare yeasts is an emerging concern in healthcare settings.
- A systematic epidemiologic study was needed to understand this trend.
Purpose of the Study:
- To investigate the epidemiological features of fungaemia caused by rare yeasts.
- To describe the clinical characteristics of these infections in pediatric intensive care units (PICUs).
Main Methods:
- Prospective observational study of yeast isolates from blood cultures in PICUs.
- Molecular identification of yeasts, categorizing non-common Candida species as rare.
- Antifungal susceptibility testing and comparison of clinical parameters between common and rare yeast fungaemia.
Main Results:
- Rare yeasts accounted for 61.6% of fungaemia cases (127/207 isolates).
- Wickerhamomyces anomalus (43.8%) and Candida utilis (40.8%) were predominant rare yeasts.
- Significant associations found with surgical intervention and gastrointestinal disease; overall mortality was 65.3%.
Conclusions:
- The rise of rare yeasts, particularly W. anomalus and C. utilis, in pediatric fungaemia requires immediate attention.
- Urgent strategies are needed to control the spread of these resistant fungal infections.
Related Concept Videos
Fungal Phylum Microsporidia
Fungal Group Zygomycota
Fungal Phylum Ascomycota
Overview of Fungi

